Syapse
About Syapse
Syapse is a healthcare AI company dedicated to advancing precision medicine, particularly in oncology, through the generation and application of real-world evidence. The company’s platform is designed to integrate previously fragmented clinical, molecular, treatment, and health outcomes data, transforming it into actionable insights. This empowers physicians, especially oncologists, to deliver personalized care at the point of care by providing comprehensive patient insights derived from real-world data.
Syapse collaborates with leading health systems, life sciences companies, and regulators to build a “Learning Health Network.” This network aims to improve outcomes in cancer care by facilitating data sharing and the application of real-world evidence, ultimately striving to ensure all cancer patients have access to the best precision care, regardless of their location or income. Their solutions support the clinical implementation of oncology precision medicine through genomic data integration, decision support, care coordination, and quality improvement.
By leveraging advanced technologies, Syapse plays a pivotal role in making healthcare more personalized and efficient. Their efforts are focused on bridging gaps in access to quality care, particularly in underserved communities, to ensure patients receive the most effective treatments based on the latest research and clinical insights.
What Physicians Need to Know
For physicians, Syapse's tools offer the ability to deliver personalized cancer care by integrating clinical and genomic data, providing actionable insights at the point of care. The platform empowers oncologists with real-world evidence, allowing them to view treatments and outcomes from a broad network of patients to inform their own treatment decisions. It also streamlines access to relevant clinical trials and supports Molecular Tumor Boards in recommending targeted therapies, ultimately aiming to improve patient outcomes and increase progression-free survival.
Syapse was acquired by N-Power Medicine on December 30, 2024. As a result, Syapse's extensive network of community-based health systems, its data and technology stack, and its dedicated team are now integrated into N-Power Medicine's AI-powered point-of-care platform and Kaleido Registry. This integration aims to establish a larger community-based prospective clinical research network, enhancing access to clinical trials for community oncologists and patients, particularly in underserved populations. Key technologies mentioned in Syapse's stack include MongoDB, React, Oracle, and HTTP/3, alongside their AI-enhanced data platform, Raydar.
What the Web Says
Syapse, a company focused on enabling precision medicine for cancer patients, receives mixed reviews regarding both its product and its work environment. While some employees praise its mission and supportive culture, others criticize management, product ambiguity, and a toxic work atmosphere. Product reviews are scarce on major platforms like G2 and Capterra for the specific 'Syapse' company focused on precision medicine, but other companies with 'Synapse' in their name (e.g., Synapse by Patsnap, Synapse Medicine, Synapse Health, Synapse Software, and Razer Synapse) have reviews available, making it crucial to distinguish between them.
Overall: MixedStrengths
- Meaningful mission in precision medicine for cancer patients.
- Supportive management and respectful colleagues (in some departments).
- Good PTO and healthcare benefits.
- Opportunities to socialize and emphasis on work-life balance.
- Potential for making a tangible impact in healthcare.
- Product helps perform warehouse duties within a single system (for Synapse Warehouse Management System).
Limitations
- Challenging and toxic work environment with political dynamics.
- Loads of ambiguity in product, requirements, expectations, and timelines.
- Terrible product that provides no value or revenue streams, with useless data (according to some employees).
- Unreliable PMO and misaligned executive leadership.
- Constant ridicule and intimidation behavior by managers.
- Poor work-life balance, pay, benefits, job security, and advancement ratings.
Based on reviews from: Indeed.com, G2.com, Reddit, Capterra, Elion Health, BevNET.com
Last updated: 2026-07-22
Videos
News, demos, and interviews about Syapse.
Videos load interactively. If none appear, search YouTube for Syapse →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Syapse.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]